OKT3 for the treatment of steroid-resistant acute renal allograft rejection

Nephron

Volumn 77, Issue 3, 1997, Pages 298-303

  Jagose, Jinni T ^a   Bailey, Ross R ^a   Lynn, Kelvin L ^a   Wells, Elisabeth ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Monoclonal antibody; OKT3; Renal transplantation; Steroid resistant rejection

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; OKT 3; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILL; CLINICAL ARTICLE; COUGHING; DIARRHEA; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; GRAFT SURVIVAL; HEADACHE; HUMAN; HYPOTENSION; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; MALE; MYALGIA; NEUROTOXICITY; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; ADULT; AGED; DRUG RESISTANCE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MUROMONAB-CD3; STEROIDS;

EID: 0030660668     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190291     Document Type: Article

References (18)

1. Mochon M, Kaiser B, Palmer JA, Polinsky M, Flynn JT, Caputo CG, Baluarte HJ: Evaluation of OKT3 monoclonal antibody and antithymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants. Pediatr Nephrol 1993:7:259-262.
2. Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmoni-co FL, Russell PS: Use of monoclonal antibody to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 1981;305:308-314.
3. Schroeder TJ, Hariharan S, First MR: Antibody response to OKT3 and methods for monitoring. Transplant Proc 1993;25:77-80.
4. Shmueli D, Nakache R, Lustig S, Nathan NB, Yussim A, Shaharabani E, Geier A, Shapira Z: OKT3 for steroid-resistant renal allograft rejection: Differential response in adults and children. Transplant Proc 1994;26:1948-1949.
5. Kehinde EO, Scriven SD. Feehally J, Veitch PS. Varty K, Bell PRF: Adverse effects of OK'D therapy: Inceased risk with impaired renal function. Transplant Proc 1994;26:1945-1947.
6. Deierhoi MH, Barber WH, Curtis JJ, Julian BA, Luke RG, Hudson S, Barger BO, Diethelm AG: Treatment of acute rejection by monoclonal. A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection. Am J Kidney Dis 1988:11:86-89.
7. Petrie JJB, Rigby RJ. Hawley CM, Suranyi MG. Whitby M, Wall D, Hardie IR: Effect of OKT3 in steroid-resistant renal transplant rejection. Transplantation 1995;59:347-352.
8. Yuan Z-F, Bailey RR, Gardner J: Cyclosporin in renal transplantation: A 9-year experience. NZ Med J 1995;108:29-32.
9. Walker RJ, Turner JG, Lynn KL, Swainson CP. Rogers TGH. Bailey RR. Radionuclide perfusion scans in the assessment of acute renal transplant rejection. NZ Med J 1985:98:428-430.
10. Solez K, Axelson RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunhill MS, Halloran PF: International standardization of criteria for the histologic diagnosis of renal allograft rejection. The Banff working classification of kidney transplant pathology. Kidney Int 1993:44:411-422.
11. Racusen LC, Rayner DC, Tropkov K; Olsen S, Solez K: The Banff classification of renal allograft pathologv: Where do we go from here? Transplant Proc 1995;27:2561-2563.
12. Jardine DL, Sizeland PCB, Bailey RR. Mason C, Ikram R, Chambers ST: Epstein-Barr virus infection acquired from a cadaveric renal transplant. Nephron 1991:58:359-361.
13. Ortho Multicenter Transplant Study Group: A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985:313:337-342.
14. Goldstein G, Norman DJ, Shield CF III, Kreis H, Burdiek J, Flye MW, Rivolta E, Starzl T, Monaco A: OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments; in Meryman HT (ed): Transplantation: Approaches to Graft Rejection. New York, Liss, 1986, pp 239-249.
15. Norman DJ, Barry JM, Bennett WM, Leone M, Henell K, Funnell B, Hubert B: The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy. Am J Kidney Dis 1988; 11:90-93.
16. Thistlethwaite JR Jr., Stuart JK, Mayes JT, Gaber AO, Stuart FP: Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis 1988:11: 94-98.
17. Dunhill MS: Histopathology of renal allograft rejection: in Morris PJ (ed): Kidney Transplantation: Principles and Practice. Philadelphia. Saunders, 1994, pp 266-285.
18. Claesson K, Tufveson G, Wahlberg J: Treatment with poly- and monoclonal antilymphocyte antibodies: Assessment of efficacy and safety in transplantation. Transplant Proc 1992:24:314.